New study aims to boost alcohol treatment in liver disease patients

NCT ID NCT06269510

Recruiting now Knowledge-focused Sponsor: Henry Ford Health System Source: ClinicalTrials.gov ↗

First seen Feb 03, 2026 · Last updated May 24, 2026 · Updated 14 times

Summary

This study looks at whether giving people with alcohol-related liver disease personalized options for alcohol treatment helps them actually start treatment and clears up any wrong ideas they may have. About 268 adults from University of Michigan clinics or hospitals will take part. The goal is to see if offering choices like one-on-one therapy, group support, or online programs increases engagement and improves liver health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Henry Ford Health
RECRUITING

Detroit, Michigan, 48202, United States

Contact Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.